Calcineurin inhibitors are immunosuppressive drugs which suppress the immune system to reduce the risk and recurrence of transplant rejection. These drugs have been a key part of the management regimen for organ transplant patients including heart, lung, liver, kidney, and pancreas transplants to reduce the risk of organ rejection. The global Calcineurin Inhibitor Market is estimated to be valued at US$ 10.07 Bn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 ... Read more
